168 related articles for article (PubMed ID: 10068662)
1. Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-L-iduronidase deficiency.
Lutzko C; Kruth S; Abrams-Ogg AC; Lau K; Li L; Clark BR; Ruedy C; Nanji S; Foster R; Kohn D; Shull R; Dubé ID
Blood; 1999 Mar; 93(6):1895-905. PubMed ID: 10068662
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease.
Lutzko C; Omori F; Abrams-Ogg AC; Shull R; Li L; Lau K; Ruedy C; Nanji S; Gartley C; Dobson H; Foster R; Kruth S; Dubé ID
Hum Gene Ther; 1999 Jun; 10(9):1521-32. PubMed ID: 10395377
[TBL] [Abstract][Full Text] [Related]
3. Myoblast gene therapy in canine mucopolysaccharidosis. I: Abrogation by an immune response to alpha-L-iduronidase.
Shull RM; Lu X; McEntee MF; Bright RM; Pepper KA; Kohn DB
Hum Gene Ther; 1996 Aug; 7(13):1595-603. PubMed ID: 8864760
[TBL] [Abstract][Full Text] [Related]
4. Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors.
Carter RF; Abrams-Ogg AC; Dick JE; Kruth SA; Valli VE; Kamel-Reid S; Dubé ID
Blood; 1992 Jan; 79(2):356-64. PubMed ID: 1309669
[TBL] [Abstract][Full Text] [Related]
5. Engraftment of gene-marked hematopoietic progenitors in myeloma patients after transplant of autologous long-term marrow cultures.
Stewart AK; Sutherland DR; Nanji S; Zhao Y; Lutzko C; Nayar R; Peck B; Ruedy C; McGarrity G; Tisdale J; Dubé ID
Hum Gene Ther; 1999 Aug; 10(12):1953-64. PubMed ID: 10466629
[TBL] [Abstract][Full Text] [Related]
6. In utero injection of alpha-L-iduronidase-carrying retrovirus in canine mucopolysaccharidosis type I: infection of multiple tissues and neonatal gene expression.
Meertens L; Zhao Y; Rosic-Kablar S; Li L; Chan K; Dobson H; Gartley C; Lutzko C; Hopwood J; Kohn D; Kruth S; Hough MR; Dubé ID
Hum Gene Ther; 2002 Oct; 13(15):1809-20. PubMed ID: 12396614
[TBL] [Abstract][Full Text] [Related]
7. Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts.
Huang MM; Wong A; Yu X; Kakkis E; Kohn DB
Gene Ther; 1997 Nov; 4(11):1150-9. PubMed ID: 9425437
[TBL] [Abstract][Full Text] [Related]
8. Preclinical assessment of human hematopoietic progenitor cell transduction in long-term marrow cultures.
Dubé ID; Kruth S; Abrams-Ogg A; Kamel-Reid S; Lutzko C; Nanji S; Ruedy C; Singaraja R; Wild A; Krygsman P; Chu P; Messner H; Reddy V; McGarrity G; Stewart AK
Hum Gene Ther; 1996 Nov; 7(17):2089-100. PubMed ID: 8934223
[TBL] [Abstract][Full Text] [Related]
9. Mobilization and transduction of peripheral blood progenitor cells in patients with mucopolysaccharidosis I.
Hubel A; Stroncek D; Pan D; Whitley CB; McCullough J
J Hematother; 1998 Dec; 7(6):505-14. PubMed ID: 9919944
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer into hematopoietic stem cells: long-term maintenance of in vitro activated progenitors without marrow ablation.
Bienzle D; Abrams-Ogg AC; Kruth SA; Ackland-Snow J; Carter RF; Dick JE; Jacobs RM; Kamel-Reid S; Dubé ID
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):350-4. PubMed ID: 8278392
[TBL] [Abstract][Full Text] [Related]
11. Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow.
Fairbairn LJ; Lashford LS; Spooncer E; McDermott RH; Lebens G; Arrand JE; Arrand JR; Bellantuono I; Holt R; Hatton CE; Cooper A; Besley GT; Wraith JE; Anson DS; Hopwood JJ; Dexter TM
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2025-30. PubMed ID: 8700879
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune response limits gene therapy in canine MPS I.
Shull R; Lu X; Dubé I; Lutzko C; Kruth S; Abrams-Ogg A; Kiem HP; Goehle S; Schuening F; Millan C; Carter R
Blood; 1996 Jul; 88(1):377-9. PubMed ID: 8704199
[No Abstract] [Full Text] [Related]
13. Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy.
Traas AM; Wang P; Ma X; Tittiger M; Schaller L; O'donnell P; Sleeper MM; Vite C; Herati R; Aguirre GD; Haskins M; Ponder KP
Mol Ther; 2007 Aug; 15(8):1423-31. PubMed ID: 17519893
[TBL] [Abstract][Full Text] [Related]
14. Clonal diversity of primitive human hematopoietic progenitors following retroviral marking and long-term engraftment in immune-deficient mice.
Dao MA; Yu XJ; Nolta JA
Exp Hematol; 1997 Dec; 25(13):1357-66. PubMed ID: 9406995
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome.
Gentner B; Tucci F; Galimberti S; Fumagalli F; De Pellegrin M; Silvani P; Camesasca C; Pontesilli S; Darin S; Ciotti F; Sarzana M; Consiglieri G; Filisetti C; Forni G; Passerini L; Tomasoni D; Cesana D; Calabria A; Spinozzi G; Cicalese MP; Calbi V; Migliavacca M; Barzaghi F; Ferrua F; Gallo V; Miglietta S; Zonari E; Cheruku PS; Forni C; Facchini M; Corti A; Gabaldo M; Zancan S; Gasperini S; Rovelli A; Boelens JJ; Jones SA; Wynn R; Baldoli C; Montini E; Gregori S; Ciceri F; Valsecchi MG; la Marca G; Parini R; Naldini L; Aiuti A; Bernardo ME;
N Engl J Med; 2021 Nov; 385(21):1929-1940. PubMed ID: 34788506
[TBL] [Abstract][Full Text] [Related]
16. Targeting a Pre-existing Anti-transgene T Cell Response for Effective Gene Therapy of MPS-I in the Mouse Model of the Disease.
Squeri G; Passerini L; Ferro F; Laudisa C; Tomasoni D; Deodato F; Donati MA; Gasperini S; Aiuti A; Bernardo ME; Gentner B; Naldini L; Annoni A; Biffi A; Gregori S
Mol Ther; 2019 Jul; 27(7):1215-1227. PubMed ID: 31060789
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Testing of the Safety and Tolerability of Lentiviral Vector-Mediated Above-Normal Alpha-L-Iduronidase Expression in Murine and Human Hematopoietic Cells Using Toxicology and Biodistribution Good Laboratory Practice Studies.
Visigalli I; Delai S; Ferro F; Cecere F; Vezzoli M; Sanvito F; Chanut F; Benedicenti F; Spinozzi G; Wynn R; Calabria A; Naldini L; Montini E; Cristofori P; Biffi A
Hum Gene Ther; 2016 Oct; 27(10):813-829. PubMed ID: 27431943
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of genetically modified human hematopoietic stem cells into preimmune canine fetuses.
Omori F; Lutzko C; Abrams-Ogg A; Lau K; Gartley C; Dobson H; Nanji S; Ruedy C; Singaraja R; Li L; Stewart AK; Kruth S; Dubé ID
Exp Hematol; 1999 Feb; 27(2):242-9. PubMed ID: 10029163
[TBL] [Abstract][Full Text] [Related]
19. Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I.
Pan D; Aronovich E; McIvor RS; Whitley CB
Gene Ther; 2000 Nov; 7(21):1875-83. PubMed ID: 11110421
[TBL] [Abstract][Full Text] [Related]
20. In vitro maintenance and retroviral transduction of human myeloma cells in long-term marrow cultures.
Stewart AK; Prince HM; Cappe D; Chu P; Lutzko C; Sutherland DR; Dubé ID
Cancer Gene Ther; 1997; 4(3):148-56. PubMed ID: 9171933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
